A thymidylate synthase polymorphism is associated with increased risk for bone toxicity among children treated for acute lymphoblastic leukemia
Yaron Finkelstein, Traci M. Blonquist, Veena Vijayanathan, Kristen E. Stevenson, Donna S. Neuberg, Lewis B. Silverman, Lynda M. Vrooman, Stephen E. Sallan, Peter D. Cole
Dive into the research topics of 'A thymidylate synthase polymorphism is associated with increased risk for bone toxicity among children treated for acute lymphoblastic leukemia'. Together they form a unique fingerprint.